| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6119831 | Journal of Clinical Virology | 2015 | 4 Pages |
Abstract
The DPP® technology showed no significant improvement for detecting early infections over other lateral-flow RTs used in the U.S. Without more data on the DPP® HIV-1/2 assay, especially from whole blood and oral fluid specimens collected during the early phase of infection, its performance as point-of-care technology remains to be assessed.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Silvina Masciotra, Krystin A. Price, Patrick Sprinkle, Laura Wesolowski, S. Michele Owen,